2027 ICD-10-CM Diagnosis Code J84.89Other specified interstitial pulmonary diseases

ICD-10-CM Codes›J00–J99›J80-J84›J84

ICD-10-CM J84.89
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

J84.89 is a billable ICD-10-CM diagnosis code for other specified interstitial pulmonary diseases. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 196 through 198. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified lower respiratory disease.

For Medicare Advantage risk adjustment, J84.89 maps to CMS-HCC Category 280 (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders) under the V28 model, adding a risk factor of about 0.319 for a community, non-dual, aged beneficiary in payment year 2027.

Code Identity

ICD-10-CM Code
J84.89
Billable Status
Yes — Valid for Submission
Code Describes
Other specified interstitial pulmonary diseases
Short Description
Other specified interstitial pulmonary diseases
Same as the full description in the CMS dataset.
Parent Code
Other specified interstitial pulmonary diseases

Code Classification

ChapterJ00–J99Diseases of the respiratory system
SectionJ80-J84Other respiratory diseases principally affecting the interstitium
CategoryJ84Other interstitial pulmonary diseases
This CodeJ84.89Other specified interstitial pulmonary diseases

Medicare Risk Adjustment (HCC)Billing

J84.89 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.

CMS-HCC V28 Category (Payment Model)
HCC 280— Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders
Payment HCC · PY 2027 one of 79 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.319
community, non-dual, aged · ranges 0.209–0.390 across segments
Hierarchy
Superseded by HCC 276, HCC 277, HCC 278, and HCC 279
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 112
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 112 · ESRD (V21): HCC 112 · ESRD (V24): HCC 112
ESRD V21 weights: 0.066 dialysis, 0.281–0.299 functioning graft · ESRD V24 weights: 0.058 dialysis, 0.080–0.256 functioning graft
Part D (RxHCC)
RxHCC 227 — Pulmonary Fibrosis, Except Idiopathic
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acute endogenous lipoid pneumonitis
  • Cholesterol pneumonitis
  • Chronic chemical respiratory disease
  • Chronic endogenous lipoid pneumonitis
  • Chronic pneumonitis of infancy
  • Combined interstitial lung disease
  • Deficiency of DNA repair
  • Diffuse pulmonary meningotheliomatosis
  • DNA repair
  • Endogenous lipoid pneumonia due to bronchial obstruction
  • Endogenous lipoid pneumonia due to genetic disease
  • Endogenous lipoid pneumonia due to infectious disease
  • Endogenous lipoid pneumonitis
  • GIP - Giant cell interstitial pneumonitis
  • Interstitial lung disease due to ABCA3 deficiency
  • Interstitial pneumonitis
  • Interstitial pneumonitis with autoimmune features
  • Late effect of respiratory tuberculosis
  • Lung disease, immunodeficiency, chromosome breakage syndrome
  • Nonspecific interstitial pneumonia
  • Occupational pleuroparenchymal fibroelastosis
  • Organized pneumonia
  • Pleuroparenchymal fibroelastosis
  • Pleuroparenchymal fibroelastosis due to connective tissue disease
  • Pleuroparenchymal fibroelastosis due to hypersensitivity pneumonitis
  • Pleuroparenchymal fibroelastosis following pulmonary tuberculosis
  • Pleuroparenchymal fibroelastosis following transplantation of lung
  • Secondary nonspecific interstitial pneumonia
  • Secondary pleuroparenchymal fibroelastosis
  • Secondary usual interstitial pneumonia
  • Sequelae of tuberculosis
  • Usual interstitial pneumonia
  • Usual interstitial pneumonia with interstitial pneumonia with autoimmune features
  • Vinyard sprayers' lung

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to J84.89: its own notes plus those printed at J84.8, J84, and Chapter 10. A note printed at a category, block or chapter applies to every code under it.

Applicable To

Conditions this code is used for: synonyms of the title or, for "other specified" codes, the conditions assigned to it. The list is not exhaustive.

  • Endogenous lipoid pneumonia
  • Interstitial pneumonitis
  • Non-specific interstitial pneumonitis NOS
  • Organizing pneumonia NOS

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

On J84.89 itself
  • cryptogenic organizing pneumonia (J84.116)
  • idiopathic non-specific interstitial pneumonitis (J84.113)
  • lipoid pneumonia, exogenous or unspecified (J69.1)
  • lymphoid interstitial pneumonia (J84.2)
From J84.8 Other specified interstitial pulmonary diseases applies to 8 codes
  • exogenous lipoid pneumonia (J69.1)
  • unspecified lipoid pneumonia (J69.1)
From J84 Other interstitial pulmonary diseases applies to 24 codes
  • drug-induced interstitial lung disorders (J70.2-J70.4)
  • interstitial emphysema (J98.2)

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From J84 Other interstitial pulmonary diseases applies to 24 codes
  • lung diseases due to external agents (J60-J70)
From Chapter 10 (J00-J99) Diseases of the respiratory system applies to 366 codes
  • certain conditions originating in the perinatal period (P04-P96)
  • certain infectious and parasitic diseases (A00-B99)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • smoke inhalation (T59.81-)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Code First

The underlying condition named in the note is sequenced before this code.

  • if applicable:
  • poisoning due to drug or toxin (T51-T65 with fifth or sixth character to indicate intent), for toxic pneumonopathy
  • underlying cause of pneumonopathy, if known

Use Additional Code

Add a second code, after this one, to fully describe the condition.

On J84.89 itself
  • code, for adverse effect, to identify drug (T36-T50 with fifth or sixth character 5), if drug-induced
From Chapter 10 (J00-J99) Diseases of the respiratory system applies to 366 codes
  • code, where applicable, to identify:
  • exposure to environmental tobacco smoke (Z77.22)
  • exposure to tobacco smoke in the perinatal period (P96.81)
  • history of tobacco dependence (Z87.891)
  • occupational exposure to environmental tobacco smoke (Z57.31)
  • tobacco dependence (F17.-)
  • tobacco use (Z72.0)

Code Also

A second code may be needed to fully describe the condition; the note gives no sequencing direction.

From J84 Other interstitial pulmonary diseases applies to 24 codes
  • if applicable, associated condition

Notes

General instructions on how these codes are used.

From Chapter 10 (J00-J99) Diseases of the respiratory system applies to 366 codes
  • When a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name J84.89, its category, or a range that includes it.

Excludes1 3

These codes carry an Excludes1 note naming J84.89: they are not reported together with it, unless the two conditions are unrelated.

  • J69.1 Pneumonitis due to inhalation of oils and essences
    endogenous lipoid pneumonia (J84.89)
  • J84.113 Idiopathic non-specific interstitial pneumonitis
    non-specific interstitial pneumonia NOS, or due to known underlying cause (J84.89)
  • J84.116 Cryptogenic organizing pneumonia
    organizing pneumonia NOS, or due to known underlying cause (J84.89)

Code Also 2

These codes say J84.89 may also be needed to fully describe the condition. The note gives no sequencing direction.

  • M34.81 Systemic sclerosis with lung involvement
    other interstitial pulmonary diseases (J84.89)
  • I27.23 Pulmonary hypertension due to lung diseases and hypoxia
    interstitial lung disease (J84.-) names J84.-, which includes this code

Index to Diseases and InjuriesGuidance

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR RSP016
Other specified and unspecified lower respiratory disease
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Interstitial Lung Diseases

Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert J84.89 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
515 Postinflam pulm fibrosis
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About J84.89Overview

What is the ICD-10 code for other specified interstitial pulmonary diseases?

The ICD-10-CM code for other specified interstitial pulmonary diseases is J84.89 (sometimes written as J8489). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is J84.89 (Other specified interstitial pulmonary diseases) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other specified interstitial pulmonary diseases on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does J84.89 group to?

When other specified interstitial pulmonary diseases is the principal diagnosis on an inpatient stay, it groups to MS-DRG 198, 197, 196, with relative weights from 0.7256 to 1.8335 depending on complications. Higher weights mean higher Medicare reimbursement.

Can J84.89 be reported with J84.116?

Not as a rule. The Excludes1 note on J84.89 lists "cryptogenic organizing pneumonia (J84.116)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).

Does J84.89 need an additional code?

When the condition applies, yes. The Use Additional Code note reads: code, for adverse effect, to identify drug (T36-T50 with fifth or sixth character 5), if drug-induced. The additional code is reported after J84.89.

What HCC is J84.89?

J84.89 (other specified interstitial pulmonary diseases) maps to CMS-HCC Category 280 (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders), commonly written as HCC 280, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It mapped to HCC 112 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 227.

Does J84.89 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, J84.89 adds a risk adjustment factor of about 0.319 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.209 to 0.390 depending on the payment segment). A more severe related category (HCC 276, HCC 277, HCC 278, and HCC 279) supersedes it when both are reported. See the full factor table on the HCC 280 category page.